Abstract:Abstract Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose Special consideration is needed when intravenous drugs are administered simultaneously using a Y-site connector. This study aimed to investigate the physical compatibility of colistin with 6 analgesics at concentrations commonly used in clinical practice. Methods A pharmaceutical preparation of colistin was dissolved according to the manufacturer’s instructions and diluted to a concentration of 1.5 mg/mL or 0.67 mg/mL (of colistin base). Simulated administration via Y-site infusion set was performed by mixing 5 mL of colistin solution with an equal volume of a solution of one of 6 intravenous analgesics. Infusion solutions of ibuprofen, ketoprofen, metamizole sodium, morphine sulfate, paracetamol, and tramadol hydrochloride were studied. For each analgesic tested, concentrates for injection were diluted with 2 solvents, resulting in 11 different combinations with each concentration of the colistin solution. The mixtures were visually inspected, and their turbidity was measured directly after mixing and at 3 consecutive time points (30, 60, and 120 minutes). Additionally, the pH of the mixtures was measured after 120 minutes and compared with the pH of the analgesic and the colistin solutions. Results During visual inspection with the unaided eye, no precipitate formation or gas evolution was observed in any of the tested analgesics except for sodium metamizole, where the yellow color of the solutions was observed. For samples containing the mixture of ibuprofen and colistin, the turbidity measurements revealed the presence of turbidity in the studied mixtures. The greatest change in pH relative to the value immediately after preparation was noted for combinations of ketoprofen and morphine sulfate with the tested antibiotic. Conclusion Colistin was found to be incompatible with ibuprofen and metamizole sodium formulations. It should also not be combined with morphine sulfate due to the significant differences in the pH value of the preparations. The colistin 0.67 mg/mL and 1.5 mg/mL infusion solutions were physically compatible with ketoprofen, tramadol hydrochloride, and paracetamol.

Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery

In Vitro Interactions of Micafungin with Amphotericin B, Itraconazole or Fluconazole Against the Pathogenic Phase of Penicillium Marneffei.

Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration

Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration

In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales

In Vitro Synergistic Antifungal Activities of Caspofungin in Combination with Fluconazole or Voriconazole Against Candida Species Determined by the Etest Method

Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration

Whole-body physiology-based pharmacokinetics of caspofungin for general patients, intensive care unit patients and hepatic insufficiency patients

The Physicochemical Compatibility of Sildenafil Injection with Parenteral Medications Used in Neonatal Intensive Care Settings

Drug compatibility with various closed intravenous infusion containers

Efficacy and Safety of Combination Antifungals As Empirical, Preemptive, and Targeted Therapies for Invasive Fungal Infections in Intensive-Care Units

Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations

Antifungal Activity of Antifungal Drugs, as Well as Drug Combinations Against Exophiala dermatitidis

Physical compatibility of colistin with analgesics during simulated Y-site administration

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children with Allogeneic Hematopoietic Stem Cell Transplantation

In Vitro Susceptibility Testing of Aspergillus Spp. Against Voriconazole, Itraconazole, Posaconazole, Amphotericin B and Caspofungin

Antifungal activity of combination of caspofungin and voriconazole, itraconazole or amphotericin B against clinical strains of Scedosporium apiospermum in vitro

An in Vitro Study on the Compatibility and Precipitation of a Combination of Ciprofloxacin and Vancomycin in Human Vitreous

Factors Influencing Caspofungin Plasma Concentrations in Kidney Transplant Patients with High Incidence of Invasive Fungal Infections.

Caspofungin enhances the potency of rifampin against Gram-negative bacteria

Pharmacokinetic/pharmacodynamic Adequacy of Echinocandins Against Candida Spp. in Intensive Care Unit Patients and General Patient Populations.